Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer

Saip, P.Eralp, Y.Ozkan, M.Karaca, H.Benekli, M.Cetin, B.Isikdogan, A.2024-04-242024-04-2420110732-183X1527-7755https://doi.org/10.1200/jco.2011.29.15_suppl.e13079https://hdl.handle.net/11468/18274[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancerPhase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancerConference Object2915WOS:00020888030330410.1200/jco.2011.29.15_suppl.e13079Q1